Tara Gregory is an Oncology physician. OpenAlex indexes 62 publications with 1,088 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1721 E 19th Ave Ste 300
Denver, CO 802181258
Telephone
720-754-4800Registry record last updated 21 Oct 2019.
Industry payments
33 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Scientific Affairs, LLCProgram year20251 payment
- Janssen Global Services, LLCProgram year20252 payments
- Janssen Biotech, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
82%CD38-directed Cytolytic Antibody79.3%Daratumumab100%Part B, office-administered≥29 patientsKinase inhibitor1.4%Jakafi46%Brukinsa23%Imbruvica21%Imatinib Mesylate10%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
9.7%Osmotically acting laxatives5.5%Magnesium sulfate100%Part B, office-administered≥25 patientsSerotonin-3 Receptor Antagonist2.9%Ondansetron hydrochloride87%Ondansetron Odt13%Part D + Part B≥18 patients+ 7 more classes in this area
Anti-infectives
2%Short-acting sulfonamides0.8%Sulfamethoxazole-Trimethoprim100%Part D≥20 patientsHerpesvirus Nucleoside Analog DNA Polymerase Inhibitor0.4%Valacyclovir100%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Prophylactic Dexamethasone Rescues Unrestrained Lymphocyte Expansion in Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma
Biology of Blood and Marrow Transplantation
2025 - Comparative Efficacy of Bendamustine Versus Fludarabine/Cyclophosphamide for Lymphodepletion Before Chimeric Antigen Receptor T-Cell Therapy in Lymphoma
Biology of Blood and Marrow Transplantation
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Freddie Bray
Centre National de la Recherche Scientifique
Jacques Ferlay
Centre international de recherche sur le cancer
Hermann Brenner
German Cancer Research Center
Isabelle Soerjomataram
Centre international de recherche sur le cancer
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”